The New Paper

December 9, 2020

FDA releases documents suggesting Pfizer vaccine meets success criteria

The FDA released documents suggesting that Pfizer and BioNTech’s vaccine met the success criteria required for emergency approval yesterday. The documents were released ahead of a meeting tomorrow to discuss potential authorization. The companies received emergency approval from UK regulators last week, with the first patients receiving doses yesterday.

Extra: Separately, the UAE announced that a vaccine developed in China is 86% effective based on interim results from late-stage trials. Additional detail on trial data and potential side effects was not provided. The China-developed vaccine is one of two that Morocco plans to use as part of an effort to vaccinate 80% of adults.

This story is from the December 9, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.